trans-(3-Fluorocyclobutyl)MethaMine hydrochloride
- $640 - $1518
- Product name: trans-(3-Fluorocyclobutyl)MethaMine hydrochloride
- CAS: 1260664-80-9
- MF: C5H10FN
- MW: 103.14
- EINECS:
- MDL Number:MFCD22570264
- Synonyms:trans-(3-Fluorocyclobutyl)MethaMine hydrochloride;trans-3-Fluorocyclobutyl methanamine;trans-(3-Fluorocyclobutyl)methamine hydrochloride - F11496;trans-(3-Fluorocyclobutyl)methanamine hydrochloride;Cyclobutanemethanamine, 3-fluoro-, trans-
3 prices
Selected condition:
Brand
- Chemenu
- SynQuest Laboratories
Package
- 250mg
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM106318
- Product descriptiontrans-(3-fluorocyclobutyl)methanaminehydrochloride 97%
- Packaging5g
- Price$1518
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM106318
- Product descriptiontrans-(3-fluorocyclobutyl)methanaminehydrochloride 97%
- Packaging1g
- Price$704
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number3230-7-02
- Product descriptiontrans-(3-Fluorocyclobutyl)methanamine hydrochloride
- Packaging250mg
- Price$640
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM106318 | trans-(3-fluorocyclobutyl)methanaminehydrochloride 97% | 5g | $1518 | 2021-12-16 | Buy |
Chemenu | CM106318 | trans-(3-fluorocyclobutyl)methanaminehydrochloride 97% | 1g | $704 | 2021-12-16 | Buy |
SynQuest Laboratories | 3230-7-02 | trans-(3-Fluorocyclobutyl)methanamine hydrochloride | 250mg | $640 | 2021-12-16 | Buy |
Properties
Boiling point :123.7±13.0 °C(Predicted)
Density :1.00±0.1 g/cm3(Predicted)
pka :10.27±0.29(Predicted)
Density :1.00±0.1 g/cm3(Predicted)
pka :10.27±0.29(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|